{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:26:38Z","timestamp":1783445198872,"version":"3.54.6"},"reference-count":16,"publisher":"Bioscientifica","issue":"3","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":3866,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background: The development of Graves' disease (GD) after subacute thyroiditis (SAT) is very rare and only a limited number of cases have been reported. Objectives: Here, we report a patient with SAT followed by hypothyroidism and later GD, with ophthalmopathy, occurring 11 years after SAT. Conclusion: This case illustrates the appearance of thyroid-stimulating hormone (TSH) receptor antibodies in a female 1 year after SAT, the development of hypothyroidism requiring thyroxine, and later the occurrence of GD with severe ophthalmopathy, 11 years after SAT. The occurrence of SAT and GD may be coincidental but SAT may have induced the appearance of TSH-receptor antibodies, with the bioactivity changing from blocking, leading to hypothyroidism, and later to a stimulating activity that led to GD in a genetically susceptible patient.<\/jats:p>","DOI":"10.1159\/000435915","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T17:01:17Z","timestamp":1437152477000},"page":"197-200","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":9,"title":["Presence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report"],"prefix":"10.1530","volume":"4","author":[{"given":"Bengt","family":"Hallengren","sequence":"first","affiliation":[{"name":"1Departments of Endocrinology, Sk\u00e5ne University Hospital, Malm\u00f6"},{"name":"3Department of Clinical Sciences, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Planck","sequence":"additional","affiliation":[{"name":"1Departments of Endocrinology, Sk\u00e5ne University Hospital, Malm\u00f6"},{"name":"3Department of Clinical Sciences, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"\u00c5sman","sequence":"additional","affiliation":[{"name":"2Departments of Ophthalmology, Sk\u00e5ne University Hospital, Malm\u00f6"},{"name":"3Department of Clinical Sciences, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Lantz","sequence":"additional","affiliation":[{"name":"1Departments of Endocrinology, Sk\u00e5ne University Hospital, Malm\u00f6"},{"name":"3Department of Clinical Sciences, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2015,7,18]]},"reference":[{"key":"2026070712461250800_ref1","doi-asserted-by":"crossref","unstructured":"Fatourechi V, Aniszevski JP, Fatourechi GZE, Atkinson EJ, Jacobsen SJ: Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minn. Study. J Clin Endocrinol Metab 2003;88:2100-2105.10.1210\/jc.2002-02179912727961","DOI":"10.1210\/jc.2002-021799"},{"key":"2026070712461250800_ref2","doi-asserted-by":"crossref","unstructured":"Perloff WH: Thyrotoxicosis following acute thyroiditis. A report of 5 cases. J Clin Endocrinol Metab 1956;16:542-546.10.1210\/jcem-16-4-54213306772","DOI":"10.1210\/jcem-16-4-542"},{"key":"2026070712461250800_ref3","doi-asserted-by":"crossref","unstructured":"Werner SC: Graves' disease following acute (subacute) thyroiditis. Arch Intern Med 1979;139:1313-1315.10.1001\/archinte.1979.03630480085027583118","DOI":"10.1001\/archinte.1979.03630480085027"},{"key":"2026070712461250800_ref4","doi-asserted-by":"crossref","unstructured":"Bartalena L, Bogazzi F, Pecori F, Martino E: Graves' disease occurring after subacute thyroiditis: report of a case and review of the literature. Thyroid 1996;6:345-348.10.1089\/thy.1996.6.3458875758","DOI":"10.1089\/thy.1996.6.345"},{"key":"2026070712461250800_ref5","doi-asserted-by":"crossref","unstructured":"Hoang TD, Mai VQ, Clyde PW, Shakir KM: Simultaneous occurrence of subacute thyroiditis and Graves' disease. Thyroid 2011;21:1397-1400.10.1089\/thy.2011.025422136271","DOI":"10.1089\/thy.2011.0254"},{"key":"2026070712461250800_ref6","doi-asserted-by":"crossref","unstructured":"Nakano Y, Kurihara H, Sasaki J: Graves' disease following subacute thyroiditis. Tohoku J Exp Med 2011;225:301-309.10.1620\/tjem.225.30122112923","DOI":"10.1620\/tjem.225.301"},{"key":"2026070712461250800_ref7","doi-asserted-by":"crossref","unstructured":"Olerup O, Zetterquist H: HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique. Tissue Antigens 1991;37:197-204.10.1111\/j.1399-0039.1991.tb01872.x1685264","DOI":"10.1111\/j.1399-0039.1991.tb01872.x"},{"key":"2026070712461250800_ref8","doi-asserted-by":"crossref","unstructured":"Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-235.10.1111\/j.1399-0039.1992.tb01940.x1357775","DOI":"10.1111\/j.1399-0039.1992.tb01940.x"},{"key":"2026070712461250800_ref9","doi-asserted-by":"crossref","unstructured":"Nygaard B, Faber J, Veje A, Hegedus L, Hansen JM: Appearance of Graves'-like disease after radioiodine therapy for toxic as well as non-toxic multinodular goitre. Clin Endocrinol (Oxf) 1995;43:129-130.10.1111\/j.1365-2265.1995.tb01904.x7641405","DOI":"10.1111\/j.1365-2265.1995.tb01904.x"},{"key":"2026070712461250800_ref10","doi-asserted-by":"crossref","unstructured":"Iitaka M, Momotani N, Hisaoka T, Noh JY, Ishikawa N, Ishii J, Katayama S, Ito K: TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis. Clin Endocrinol (Oxf) 1998;48:445-453.10.1046\/j.1365-2265.1998.00416.x9640411","DOI":"10.1046\/j.1365-2265.1998.00416.x"},{"key":"2026070712461250800_ref11","doi-asserted-by":"crossref","unstructured":"Iitaka M, Kakinuma S, Yamanaka K, Fujimaki S, Oosuga I, Wada S, Katayama S: Induction of autoimmune hypothyroidism and subsequent hyperthyroidism by TSH receptor antibodies following subacute thyroiditis: a case report. Endocrine J 2001;48:139-142.10.1507\/endocrj.48.13911456259","DOI":"10.1507\/endocrj.48.139"},{"key":"2026070712461250800_ref12","doi-asserted-by":"crossref","unstructured":"Strakosch CR, Joyner D, Wall JR: Thyroid stimulating antibodies in patients with subacute thyroiditis. J Clin Endocrinol Metab 1978;46:345-348.10.1210\/jcem-46-2-345750609","DOI":"10.1210\/jcem-46-2-345"},{"key":"2026070712461250800_ref13","doi-asserted-by":"crossref","unstructured":"Wartofsky L, Schaaf M: Graves' disease with thyrotoxicosis following subacute thyroiditis. Am J Med 1987;83:761-763.10.1016\/0002-9343(87)90910-73674062","DOI":"10.1016\/0002-9343(87)90910-7"},{"key":"2026070712461250800_ref14","unstructured":"Weetman AP, Smallridge RC, Nutman TB, Burman KD: Persistent thyroid autoimmunity after subacute thyroiditis. J Clin Lab Immunol 1987;23:1-6.2441062"},{"key":"2026070712461250800_ref15","doi-asserted-by":"crossref","unstructured":"Lantz M, Planck T, \u00c5sman P, Hallengren B: Increased TRAb and\/or low anti-TPO titers at diagnosis of Graves' disease are associated with an increased risk of developing ophthalmopathy after onset. Exp Clin Endocrinol Diabetes 2014;122:113-117.10.1055\/s-0033-136319324554511","DOI":"10.1055\/s-0033-1363193"},{"key":"2026070712461250800_ref16","doi-asserted-by":"crossref","unstructured":"Khoo DH, Ho SC, Seah LL, Fong KS, Tai ES, Chee SP, Eng PH, Aw SE, Fok AC: The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid 1999;9:1175-1180.10.1089\/thy.1999.9.117510646655","DOI":"10.1089\/thy.1999.9.1175"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/435915","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/4\/3\/197\/29229\/etj435915.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/4\/3\/197\/29229\/etj435915.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:04:39Z","timestamp":1783443879000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/4\/3\/197\/3978\/Presence-of-Thyroid-Stimulating-Hormone-Receptor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,18]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000435915","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7,18]]}}}